Cargando…

Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy

Patients with chronic hepatitis C have both higher prevalence of diabetes mellitus type 2 (T2DM) and increased cardiovascular risk compared to never infected people. Sustained viral response (SVR) achievement led to decreasing incidence and prevalence of T2DM during the interferon era of HCV treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drazilova, Sylvia, Gazda, Jakub, Janicko, Martin, Jarcuska, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110000/ https://www.ncbi.nlm.nih.gov/pubmed/30186821 http://dx.doi.org/10.1155/2018/6150861

Ejemplares similares

Artificial Intelligence and Its Application to Minimal Hepatic Encephalopathy Diagnosis
por: Gazda, Jakub, et al.
Publicado: (2021)

The Epidemiology of Primary Biliary Cholangitis in European Countries: A Systematic Review and Meta-Analysis
por: Gazda, Jakub, et al.
Publicado: (2021)

IgG4-Related Sclerosing Cholangitis: Rarely Diagnosed, but not a Rare Disease
por: Drazilova, Sylvia, et al.
Publicado: (2021)

R0 Liver Resection should be a First-line Treatment for Selected Patients with Intermediate Hepatocellular Cancer
por: Janicko, Martin, et al.
Publicado: (2023)

Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia
por: Drazilova, Sylvia, et al.
Publicado: (2016)

External Validation of UDCA Response Score in Slovak and Croatian Patients with Primary Biliary Cholangitis
por: Gazda, Jakub, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Clinical Patterns, Outcomes, and Prognostic Factors for Overall Survival—A Retrospective Analysis of a Slovak Cohort
por: Safcak, Dominik, et al.
Publicado: (2021)

Alcoholic Liver Disease-Related Hepatocellular Carcinoma: Characteristics and Comparison to General Slovak Hepatocellular Cancer Population
por: Šafčák, Dominik, et al.
Publicado: (2023)

Seroprevalence of Hepatitis E Virus in Roma Settlements: A Comparison with the General Population in Slovakia
por: Halánová, Monika, et al.
Publicado: (2018)

Inflammatory Indexes as Prognostic Factors of Survival in Geriatric Patients with Hepatocellular Carcinoma: A Case Control Study of Eight Slovak Centers
por: Safcak, Dominik, et al.
Publicado: (2022)

Treatment of hepatitis C in HIV patients in the new DAA era
por: Soriano, Vicente
Publicado: (2014)

Treatment of hepatitis C virus genotype 4 in the DAA era
por: Di Biagio, Antonio, et al.
Publicado: (2018)

Prevalence and Risk Factors for Hepatitis B Virus Infection in Roma and Non-Roma People in Slovakia
por: Drazilova, Sylvia, et al.
Publicado: (2018)

Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
por: Drazilova, Sylvia, et al.
Publicado: (2018)

Prognostic Factors in Primary Biliary Cholangitis: A Retrospective Study of Joint Slovak and Croatian Cohort of 249 Patients
por: Gazda, Jakub, et al.
Publicado: (2021)

The Roma Population Living in Segregated Settlements in Eastern Slovakia Has a Higher Prevalence of Metabolic Syndrome, Kidney Disease, Viral Hepatitis B and E, and Some Parasitic Diseases Compared to the Majority Population
por: Macejova, Zelmira, et al.
Publicado: (2020)

What is the Role of the Horizontal Transmission of Hepatitis B Virus Infection in Young Adult and Middle-Aged Roma Population Living in the Settlements in East Slovakia?
por: Drazilova, Sylvia, et al.
Publicado: (2020)

Seroprevalence of Bartonella henselae and Bartonella quintana Infection and Impact of Related Risk Factors in People from Eastern Slovakia
por: Petríková, Katarína, et al.
Publicado: (2021)

Comparison of Two Diagnostic Methods for the Detection of Hepatitis B Virus Genotypes in the Slovak Republic
por: Logoida, Mariia, et al.
Publicado: (2021)

A Community-Based Study to Estimate the Seroprevalence of Trichinellosis and Echinococcosis in the Roma and Non-Roma Population of Slovakia
por: Antolová, Daniela, et al.
Publicado: (2018)

Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging
por: Hako, René, et al.
Publicado: (2019)

Serum Uric Acid in Roma and Non-Roma—Its Correlation with Metabolic Syndrome and Other Variables
por: Petrikova, Jana, et al.
Publicado: (2018)

Evaluation of hepatic fibrosis – access to non-invasive methods, national practice/guidelines in Central Europe
por: Jarcuska, Peter, et al.
Publicado: (2016)

Telehealth for Hepatitis C Care in the DAA Era; Ensuring Everyone Can Access a Cure
por: Schulz, Thomas Ray, et al.
Publicado: (2017)

Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs
por: El Sagheer, Ghada, et al.
Publicado: (2018)

Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?
por: Petta, Salvatore, et al.
Publicado: (2012)

Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration
por: Goyal, Ashish, et al.
Publicado: (2022)

Roma Ethnicity and Sex-Specific Associations of Serum Uric Acid with Cardiometabolic and Hepatorenal Health Factors in Eastern Slovakian Population: The HepaMeta Study
por: Pallayova, Maria, et al.
Publicado: (2020)

Perceived Stress in Hepatitis C Virus Infected Patients under the DAA-Based Therapy
por: Danilescu, Claudia Monica, et al.
Publicado: (2022)

Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project
por: Borghi, Claudio, et al.
Publicado: (2022)

Treatment and re-treatment results of HCV patients in the DAA era
por: Piecha, Felix, et al.
Publicado: (2020)

Depressive and Anxious Symptoms in Hepatitis C Virus Infected Patients Receiving DAA-Based Therapy
por: Danilescu, Claudia Monica, et al.
Publicado: (2021)

A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil
por: Vivaldini, Simone Monzani, et al.
Publicado: (2021)

258 Analysis of the Hepatic Microenvironment Before and After Direct-Acting Antiviral (DAA) Therapy for Viral Hepatitis C
por: Millian, Daniel, et al.
Publicado: (2023)

Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST‐HCV cohort
por: Calvaruso, Vincenza, et al.
Publicado: (2021)

Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
por: Roguljic, Hrvoje, et al.
Publicado: (2021)

Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing
por: van der Ree, Meike H., et al.
Publicado: (2017)

Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections
por: Welzel, Tania M., et al.
Publicado: (2019)

Changing Landscape of Liver Transplantation in the Post-DAA and Contemporary ART Era
por: Saeed, Huma, et al.
Publicado: (2022)

310. Disparities in Hepatitis C Linkage to Care in the DAA Era: Findings from a Referral Clinic with an Embedded Nurse Navigator Model
por: Sherbuk, Jacqueline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a7i7frsp9kh84ja9q3lpkn4me5